Annual CFI
$37.98 M
+$118.46 M+147.20%
31 December 2023
Summary:
AlloVir annual cash flow from investing activities is currently $37.98 million, with the most recent change of +$118.46 million (+147.20%) on 31 December 2023. During the last 3 years, it has risen by +$207.48 million (+122.41%). ALVR annual CFI is now -79.58% below its all-time high of $185.98 million, reached on 31 December 2021.ALVR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$20.00 M
-$10.00 M-33.33%
30 September 2024
Summary:
AlloVir quarterly cash flow from investing activities is currently $20.00 million, with the most recent change of -$10.00 million (-33.33%) on 30 September 2024. Over the past year, it has increased by +$86.85 million (+129.92%). ALVR quarterly CFI is now -74.91% below its all-time high of $79.71 million, reached on 30 June 2021.ALVR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$115.22 M
+$86.85 M+306.17%
30 September 2024
Summary:
AlloVir TTM cash flow from investing activities is currently $115.22 million, with the most recent change of +$86.85 million (+306.17%) on 30 September 2024. Over the past year, it has increased by +$88.91 million (+338.02%). ALVR TTM CFI is now -42.80% below its all-time high of $201.43 million, reached on 30 September 2021.ALVR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +147.2% | +129.9% | +338.0% |
| 3 y3 years | +122.4% | -63.6% | -42.8% |
| 5 y5 years | +100.0% | +10000.0% | +215.8% |
ALVR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -79.6% | +122.4% | -63.6% | +129.9% | -42.8% | +207.1% |
| 5 y | 5 years | -79.6% | +122.4% | -74.9% | +109.5% | -42.8% | +168.0% |
| alltime | all time | -79.6% | +122.4% | -74.9% | +109.5% | -42.8% | +168.0% |
AlloVir Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $20.00 M(-33.3%) | $115.22 M(+306.2%) |
| June 2024 | - | $30.00 M(-25.0%) | $28.37 M(-21.8%) |
| Mar 2024 | - | $40.00 M(+58.6%) | $36.26 M(-4.5%) |
| Dec 2023 | $37.98 M(-147.2%) | $25.22 M(-137.7%) | $37.98 M(+44.4%) |
| Sept 2023 | - | -$66.85 M(-276.4%) | $26.30 M(-51.8%) |
| June 2023 | - | $37.89 M(-9.2%) | $54.60 M(+236.5%) |
| Mar 2023 | - | $41.72 M(+208.2%) | $16.23 M(-120.2%) |
| Dec 2022 | -$80.48 M(-143.3%) | $13.54 M(-135.1%) | -$80.48 M(-25.2%) |
| Sept 2022 | - | -$38.56 M(+7949.5%) | -$107.54 M(+667.4%) |
| June 2022 | - | -$479.00 K(-99.1%) | -$14.01 M(-121.2%) |
| Mar 2022 | - | -$54.98 M(+306.6%) | $66.18 M(-64.4%) |
| Dec 2021 | $185.98 M | -$13.52 M(-124.6%) | $185.98 M(-7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $54.97 M(-31.0%) | $201.43 M(-415.7%) |
| June 2021 | - | $79.71 M(+23.0%) | -$63.80 M(-46.2%) |
| Mar 2021 | - | $64.83 M(+3272.9%) | -$118.51 M(-30.1%) |
| Dec 2020 | -$169.50 M(+162.2%) | $1.92 M(-100.9%) | -$169.50 M(+24.1%) |
| Sept 2020 | - | -$210.26 M(-940.9%) | -$136.54 M(-285.1%) |
| June 2020 | - | $25.00 M(+80.7%) | $73.77 M(-245.2%) |
| Mar 2020 | - | $13.84 M(-60.3%) | -$50.80 M(-21.4%) |
| Dec 2019 | -$64.64 M(<-9900.0%) | $34.88 M(>+9900.0%) | -$64.64 M(-35.0%) |
| Sept 2019 | - | $46.00 K(-100.0%) | -$99.52 M(-0.0%) |
| June 2019 | - | -$99.57 M(<-9900.0%) | -$99.57 M(<-9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is AlloVir annual cash flow from investing activities?
- What is the all time high annual CFI for AlloVir?
- What is AlloVir annual CFI year-on-year change?
- What is AlloVir quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for AlloVir?
- What is AlloVir quarterly CFI year-on-year change?
- What is AlloVir TTM cash flow from investing activities?
- What is the all time high TTM CFI for AlloVir?
- What is AlloVir TTM CFI year-on-year change?
What is AlloVir annual cash flow from investing activities?
The current annual CFI of ALVR is $37.98 M
What is the all time high annual CFI for AlloVir?
AlloVir all-time high annual cash flow from investing activities is $185.98 M
What is AlloVir annual CFI year-on-year change?
Over the past year, ALVR annual cash flow from investing activities has changed by +$118.46 M (+147.20%)
What is AlloVir quarterly cash flow from investing activities?
The current quarterly CFI of ALVR is $20.00 M
What is the all time high quarterly CFI for AlloVir?
AlloVir all-time high quarterly cash flow from investing activities is $79.71 M
What is AlloVir quarterly CFI year-on-year change?
Over the past year, ALVR quarterly cash flow from investing activities has changed by +$86.85 M (+129.92%)
What is AlloVir TTM cash flow from investing activities?
The current TTM CFI of ALVR is $115.22 M
What is the all time high TTM CFI for AlloVir?
AlloVir all-time high TTM cash flow from investing activities is $201.43 M
What is AlloVir TTM CFI year-on-year change?
Over the past year, ALVR TTM cash flow from investing activities has changed by +$88.91 M (+338.02%)